These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26458588)

  • 1. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.
    Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W
    Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
    Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice.
    Yoysungnoen P; Wirachwong P; Bhattarakosol P; Niimi H; Patumraj S
    Clin Hemorheol Microcirc; 2006; 34(1-2):109-15. PubMed ID: 16543625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1.
    Han L; Wang Y; Sun S
    Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
    Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
    Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM
    Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Zhang S; Tang D; Zang W; Yin G; Dai J; Sun YU; Yang Z; Hoffman RM; Guo X
    Anticancer Res; 2017 Feb; 37(2):465-473. PubMed ID: 28179291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
    Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
    Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway.
    Tian L; Huang Y; Liu Y; Liu J; Liu Y
    IUBMB Life; 2024 Nov; 76(11):972-986. PubMed ID: 38873890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
    Puglia C; Frasca G; Musumeci T; Rizza L; Puglisi G; Bonina F; Chiechio S
    Eur J Pharm Biopharm; 2012 Jun; 81(2):288-93. PubMed ID: 22504443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
    Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
    Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.